TABLE 1.
Baseline and clinical characteristics of the study participants
| Variable | COVID‐19 infected women (n = 61) |
|---|---|
| Age in years (mean + SD) | 51.96 + 15.24 (range: 24–75 years) |
| Reproductive aged women (number, %) | 28 (45.9%) |
| Postmenopausal women (number, %) | 33 (54.1%) |
| Parity (mean + SD) | 2.52 + 1.34 (range: 0–5) |
| Asymptomatic (number, %) | 22 (36.1%) |
| ICMR severity (number, %) | |
| Mild | 9 (14.8%) |
| Moderate | 16 (26.2%) |
| Severe | 14 (23%) |
| Presenting complaint (number, %) | |
| Fever | 31 (50.82%) |
| Shortness of breath | 22 (36.07%) |
| Cough | 14 (22.95%) |
| Chest pain | 6 (9.84%) |
| Sore throat | 4 (6.56%) |
| Diarrhea | 2 (3.28%) |
| Comorbidity (number, %) | |
| Hypertension | 27 (44.26%) |
| Diabetes mellitus | 17 (27.87%) |
| Hypothyroidism | 6 (9.84%) |
| COPD & Asthma | 3 (4.9%) |
| Tuberculosis | 2 (3.28%) |
| Chronic kidney disease | 4 (6.56%) |
| Heart disease | 2 (3.28%) |
| Other(s) | 9 (14.8%) |
| Interval from first day of COVID‐19 positivity to day of sampling (mean + SD) | 4.80 + 4.31 (range: 1–17 days; median: 3 days; IQR: 2–6 days) |
| Outcome (number, %) | |
| Recovered/discharged | 56 (91.8%) |
| Expired | 5 (8.2%) |
| Mean CT value of NP & OP swabs (mean + SD) | 26.59 + 3.57 (range: 16–33; median: 28) |
| Presence of SARS‐CoV‐2 in vaginal sample (number, %) | 5/61 (8.2%) |
| Presence of SARS‐CoV‐2 in cervical sample (number, %) | 4/38 (10.53%) |
Abbreviations: COPD, chronic obstructive pulmonary disease; ICMR, Indian Council of Medical Research; NP, Nasopharyngeal; OP, Oropharyngeal.